Medicare Enrolled
Dr. Geraldo Ramos, MD
Cardiovascular Disease · St. Petersburg, FL
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ramos from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ramos?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ramos
Dr. Geraldo Ramos is a cardiovascular disease specialist in St. Petersburg, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Ramos performed 3,765 Medicare services across 2,963 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ramos received a total of $144,604 from 37 pharmaceutical and/or device companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ramos is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 32% volume in FL
$144,604 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,765
Medicare services
Top 32% in FL for cardiovascular disease
2,963
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~221 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
862 | $6 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
724 | $89 | $311 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
485 | $10 | $35 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
207 | $131 | $471 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
164 | $53 | $75 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
160 | $130 | $498 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
135 | $61 | $179 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
119 | $117 | $409 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
111 | $91 | $257 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
108 | $38 | $121 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
86 | $99 | $433 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
80 | $321 | $1,039 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
80 | $44 | $169 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
65 | $54 | $191 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
47 | $17 | $53 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
46 | $10 | $33 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
33 | $9 | $28 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
31 | $23 | $73 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
27 | $16 | $54 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
27 | $10 | $36 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
25 | $18 | $58 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
21 | $83 | $271 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
20 | $2 | $8 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
19 | $18 | $63 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
19 | $136 | $456 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
18 | $14 | $45 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
17 | $192 | $632 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
16 | $85 | $265 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
13 | $18 | $63 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.8% high complexity
14.8% medium
75.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$144,604
Total received (2018-2024)
Avg $20,658/year across 7 years
Top 3% in FL for cardiovascular disease
37
Companies
552
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$129,422 (89.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,540 (5.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,642 (4.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$15,215
2023
$10,934
2022
$14,511
2021
$20,614
2020
$27,668
2019
$25,935
2018
$29,727
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$76,653
AstraZeneca Pharmaceuticals LP
$35,546
Lilly USA, LLC
$18,567
Lexicon Pharmaceuticals, Inc.
$7,445
Janssen Pharmaceuticals, Inc
$774
Novo Nordisk Inc
$658
Amgen Inc.
$652
Novartis Pharmaceuticals Corporation
$639
E.R. Squibb & Sons, L.L.C.
$598
Merck Sharp & Dohme LLC
$474
Amarin Pharma Inc.
$324
SANOFI-AVENTIS U.S. LLC
$295
Abbott Laboratories
$253
Medtronic Vascular, Inc.
$221
PFIZER INC.
$187
Boston Scientific Corporation
$159
Esperion Therapeutics, Inc.
$146
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$114
AbbVie Inc.
$102
Bayer Healthcare Pharmaceuticals Inc.
$98
Bayer HealthCare Pharmaceuticals Inc.
$82
Merck Sharp & Dohme Corporation
$82
SCPHARMACEUTICALS INC.
$62
Nuwellis, Inc.
$59
Medtronic, Inc.
$58
Regeneron Healthcare Solutions, Inc.
$56
ABIOMED
$46
CHF Solutions, Inc
$43
BIOTRONIK INC.
$38
ARBOR PHARMACEUTICALS, INC.
$31
Alnylam Pharmaceuticals Inc.
$29
ARALEZ PHARMACEUTICALS US INC.
$22
Braemar Manufacturing, LLC
$22
Chiesi USA, Inc.
$19
Preventice Services, LLC
$18
BOSTON SCIENTIFIC CORPORATION
$17
GE HEALTHCARE
$17
Top 3 companies account for 90.4% of total payments
Associated products mentioned in payments ›
3F · ANDEXXA · AVEIR · Aquadex · Aquadex Smartflow Console · BG Mini Plus · BRILINTA · BYDUREON · CAMZYOS · CHANTIX · Cardiac Monitoring Suite · Claria MRI · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · Edarbi · FARXIGA · FUROSCIX · INVOKANA · Impella · Inpefa · JARDIANCE · JETSTREAM · KENGREAL · Kerendia · LEQVIO · LOKELMA · LifeVest · MITRACLIP · MOUNJARO · MULTAQ · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RYBELSUS · Repatha · Reveal LINQ · Rybelsus · Saxenda · TRULICITY · Tresiba · UBRELVY · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN Access System · XARELTO · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for cardiovascular disease in FL.
Equivalent to $3,841 per 100 Medicare services performed
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ramos is an electrophysiology & cardiac specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 3% of FL peers, with 17 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ramos experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Ramos performed 862 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ramos receive payments from pharmaceutical companies?
Yes. Dr. Ramos received a total of $144,604 from 37 companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ramos's costs compare to other cardiologists in St. Petersburg?
Dr. Ramos's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ramos) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in St. Petersburg
Browse cardiologists in St. Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology